I Spoke to the company secretary a few weeks ago to get an update on this and I think what they mean by this is that Acrux are not out of pocket for having to defend this case. Not sure how it works, but the onus is all on the companies who are trying to use the patents to justify why they should be able to.
- Forums
- ASX - By Stock
- Ann: Acrux generic strategy and Axiron patent litigation update-ACR.AX
I Spoke to the company secretary a few weeks ago to get an...
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
-0.001(2.22%) |
Mkt cap ! $12.79M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.4¢ | $10.91K | 243.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 82022 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 82022 | 0.044 |
2 | 547000 | 0.043 |
2 | 94414 | 0.041 |
5 | 442500 | 0.040 |
1 | 78000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 10000 | 1 |
0.048 | 44500 | 3 |
0.049 | 120000 | 1 |
0.052 | 103000 | 2 |
0.055 | 120542 | 1 |
Last trade - 15.11pm 15/11/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online